Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STaR: Complera vs Atripla in HIV-1 Treatment-Naive Adults
NCT01309243Phase 3Completed
- Sponsor
- Gilead Sciences
- Start
- Feb 2011
- Primary completion
- Sep 2012
- Modality
- Small Molecules
- Countries
- 14
01
Overview
A Phase 3 trial of rilpivirine in human immunodeficiency virus type 1 infection (HIV-1), sponsored by Gilead Sciences. Started Feb 2011; status: completed.
02
Drugs
rilpivirine
03
Conditions
human immunodeficiency virus type 1 infection (HIV-1)
Beyond the preview
Go deeper on NCT01309243.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01309243.